The Expression and Clinical Significance of sFasL in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis

PAN Yue-fei,FU Meng,GAO Ji-xin,LI Wei,QIAO Hong-jiang,LI Chun-ying,LI Cheng-xin,WANG Gang,GAO Tian-wen,LIU Yu-feng
2013-01-01
Abstract:Objective To discuss the levels of sFasL in the serums of the patients of SJS-TEN in acute periods,ordinary types of drug-induced skin reactions and healthy control and analyse their clinical significance. Methods ELISA was used to detect the levels of sFasL in serums of 13 SJS-TEN patients,10 ordinary types of drug-induced skin reactions and 12 health control. Results The sFasL expression levels in serums of acute periods in SJS-TEN were (24.47±2.20)ng/mL ,which were obvious higher than those in ordinary types of drug-induced skin reactions(12.26±1.38)ng/mL and control(12.67±0.91)ng/mL(P<0.001),but there were no difference between ordinary types of drug-induced skin reactions and control (P>0.05),and the levels of sFasL were lower after therapy than that in acute periods. Conclusion The levels of sFasL were higher in acute periods of SJS-TEN patients,that may offered foundation for the earlier diagnosis and prognosis to the patients of SJS-TEN.
What problem does this paper attempt to address?